Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Share-based Compensation (2016 - 2025)

Healthstream (HSTM) has disclosed Share-based Compensation for 16 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 195.36% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, up 39.46% year-over-year, with the annual reading at $8.1 million for FY2025, 82.21% up from the prior year.
  • Share-based Compensation for Q4 2025 was $3.5 million at Healthstream, up from $794000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $3.5 million in Q4 2025, with the low at $616000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $1.1 million, with a median of $991500.0 recorded in 2022.
  • The sharpest move saw Share-based Compensation soared 307.61% in 2021, then tumbled 58.0% in 2022.
  • Over 5 years, Share-based Compensation stood at $2.2 million in 2021, then tumbled by 58.0% to $945000.0 in 2022, then grew by 13.97% to $1.1 million in 2023, then grew by 10.03% to $1.2 million in 2024, then soared by 195.36% to $3.5 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $3.5 million, $794000.0, and $836000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.